Our aim is to deliver the best expert and compassionate care for patients with blood diseases and those patients who need blood cell transfusions with the aim of reducing the burden of disease now and for the future through our research, clinical care, education, outreach and advocacy.
Guided by our international clinical and scientific leadership in blood disorders, we will deploy our strengths in discovery science in how the bone marrow works to make blood cells in health and disease and our unique clinical expertise in carrying out studies to:
- Improve cost-effective, cancer therapy outcomes. We will do this by developing new single cell approaches to improve curative therapy responses specific in individual patients. See our Blood Cancer and Stem/Immune Cell Transplantation Sub-Theme page for more details.
- Improve management of anaemia for both common and rare anaemias through a new national NHS service for patients with rare inherited red cell disorders (an overlooked, underprovided patient group), and scientifically guided understanding of the role of iron and inflammation in anaemic patients, especially those who are elderly. See our Red Cell Sub-Theme page for more details.
- Improve clinical outcomes from blood cell and blood component transfusion using advanced e-tools and clinical trials. See our Transfusion and Haemostasis Sub-Theme page for more details.